Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 561

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases

Open access
Khanna, Chand, Anderson, Peter M., Hasz, Diane E., Katsanis, Emmanuel, Neville, Mary, Klausner, Jeffrey S.·1997·Cancer
DOI 10.1002/(sici)1097-0142(19970401)79:7
Open this paper in CoChat — free account

Abstract

BACKGROUND: Accurate histologic diagnosis of gliomas is fundamental to proper patient management and to the interpretation of basic and clinical investigations. Diagnostic accuracy and reproducibility are compromised by the subjective histologic criteria currently used to classify and grade gliomas. METHODS: The histologic features of 4 sets of gliomas (a total of 244 cases) were reviewed independently by 4 neuropathologists to determine interobserver diagnostic concordance rates. Cases wherein diagnostic disagreements arose were reviewed jointly to identify and refine the histologic criteria that were adversely affecting diagnostic reproducibility. Using the criteria developed in the study, a set of 315 gliomas with known survival data was evaluated in order to validate the usefulness of the criteria. RESULTS: There was significant improvement in diagnostic concordance with each session (P = 0.02). For the first session, the concordance rates were as follows: all 4 reviewers, 52%; any 3 reviewers, 60%; 2 reviewers, 70%. For the fourth session, the respective rates were 69%, 75%, and 80%. Although features important in grading, particularly microvascular proliferation, were sometimes problematic, most disagreements related to the classification of tumors. Much of the improvement related to the refinement of criteria distinguishing diffuse astrocytomas from oligodendrogliomas/oligoastrocytomas and pilocytic astrocytomas. It was concluded that the presence of any typical oligodendroglioma was sufficient to remove a tumor from the astrocytoma category. CONCLUSIONS: The authors' data indicate that oligodendroglial tumors comprise up to 25% of gliomas, a significantly higher proportion than was previously recognized. The data also suggest that the wide range of survival times reported for patients with anaplastic astrocytoma may reflect "contamination" resulting from misdiagnosis, particularly of oligodendroglial tumors and pilocytic astrocytomas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/(sici)1097-0142(19970401)79:7<1409::aid-cncr19>3.0.co;2-3

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 66

  1. Potter, 1985, J Clin Oncol, 3, 353, 10.1200/JCO.1985.3.3.353 · DOI · Paper page
  2. Elias, 1989, Semin Oncol, 16, 305
  3. Kleinerman, 1995, Am J Clin Oncology, 18, 93, 10.1097/00000421-199504000-00001 · DOI
  4. Kintzel, 1991, Clin Pharmacy, 10, 110
  5. Rosenberg, 1985, N Engl J Med, 313, 1485, 10.1056/NEJM198512053132327 · DOI · Paper page
  6. Smith, 1988, Science, 240, 1169, 10.1126/science.3131876 · DOI · Paper page
  7. Sznol, 1989, Cancer Treat Rev, 15, 29, 10.1016/0305-7372(89)90020-0 · DOI
  8. Espinoza-Delgadro, 1995, J Leukoc Biol, 57, 13, 10.1002/jlb.57.1.13 · DOI
  9. Grimm, 1991, J Cell Biochem, 45, 335, 10.1002/jcb.240450405 · doi:10.1002/jcb.240450405
  10. Rubin, 1993, Cancer Invest, 11, 460, 10.3109/07357909309018878 · DOI
  11. Kaplan, 1994, J Chromatogr B Biomed Appl, 662, 315, 10.1016/0378-4347(94)00212-6 · DOI
  12. Maas, 1993, Cancer Immunol Immunother, 36, 141, 10.1007/BF01741084 · DOI
  13. Marincola, 1995, J Clin Oncol, 13, 1110, 10.1200/JCO.1995.13.5.1110 · doi:10.1200/jco.1995.13.5.1110
  14. Anderson, 1992, Drug Devel Res, 27, 15, 10.1002/ddr.430270103 · DOI
  15. Guida, 1995, Cancer Biother, 10, 195, 10.1089/cbr.1995.10.195 · doi:10.1089/cbr.1995.10.195
  16. Menzel, 1993, Cancer Biother, 8, 199, 10.1089/cbr.1993.8.199 · doi:10.1089/cbr.1993.8.199
  17. Siegal, 1991, J Clin Oncol, 9, 694, 10.1200/JCO.1991.9.4.694 · DOI · Paper page
  18. Smith, 1993, Blood, 81, 1414, 10.1182/blood.V81.6.1414.1414 · DOI
  19. Anderson, 1994, Drug Disposition, 27, 19
  20. Helfand, 1994, Cancer Immunol Immunother, 39, 84, 10.1007/BF01525313 · doi:10.1007/bf01525313
  21. Waldrep, 1994, J Aerosol Med, 7, 135, 10.1089/jam.1994.7.135 · doi:10.1089/jam.1994.7.135
  22. Knight, 1988, J Infect Dis, 158, 443, 10.1093/infdis/158.2.443 · doi:10.1093/infdis/158.2.443
  23. Hodson, 1995, Am J Respir Crit Care Med, 151, s70, 10.1164/ajrccm/151.3_Pt_2.S70 · doi:10.1164/ajrccm/151.3_pt_2.s70
  24. Malone, 1993, Chest, 104, 114, 10.1378/chest.104.4.1114 · doi:10.1378/chest.104.4.1114
  25. Maasilta, 1991, Lancet, 337, 371, 10.1016/0140-6736(91)91009-J · doi:10.1016/0140-6736(91)91009-j
  26. Dowling, 1990, Surgery, 108, 198
  27. Gilbert, 1993, Transplantation, 56, 974, 10.1097/00007890-199310000-00037 · DOI
  28. New approaches in aerosol drug delivery for the treatment of asthma. In: editor. Allergy and allergic disease. London: Blackwell Scientific, 1995.
  29. Newman, 1983, Thorax, 38, 881, 10.1136/thx.38.12.881 · doi:10.1136/thx.38.12.881
  30. Huland, 1992, J Urol, 147, 344, 10.1016/S0022-5347(17)37233-6 · doi:10.1016/s0022-5347(17)37233-6
  31. Huland, 1994, J Cancer Res Clin Oncol, 120, 221, 10.1007/BF01372560 · doi:10.1007/bf01372560
  32. Khanna, 1994, Proc Am Assoc Cancer Res, 35, 414
  33. Zhang, 1994, Proc Am Assoc Cancer Res, 35, 519
  34. Juliano, 1980, J Pharmacol Exp Ther, 214, 381
  35. Ostro, 1989, Am J Hosp Pharm, 46, 1576
  36. Anderson, 1994, Cytokines, 6, 1, 10.1016/1043-4666(94)90014-0 · DOI
  37. Kedar, 1994, J Immunother, 16, 47, 10.1097/00002371-199407000-00005 · DOI
  38. Bergers, 1993, Pharmacol Res, 10, 1715, 10.1023/A:1018913912580 · doi:10.1023/a:1018913912580
  39. Loeffler, 1990, Cancer Res, 50, 1853
  40. Niven, 1991, Pharmacol Res, 8, 217, 10.1023/A:1015896121377 · doi:10.1023/a:1015896121377
  41. Martin, 1990, J Lipid Res, 1, 407
  42. Schreier, 1993, J Control Release, 24, 209, 10.1016/0168-3659(93)90180-D · DOI
  43. Khanna, 1996, Clin Cancer Res, 4, 719
  44. Anderson, 1990, Cancer Res, 50, 1853
  45. Moore, 1992, Tissue Antigens, 40, 75, 10.1111/j.1399-0039.1992.tb01963.x · doi:10.1111/j.1399-0039.1992.tb01963.x
  46. Anderson, 1989, J Immunol, 142, 1383, 10.4049/jimmunol.142.4.1383 · DOI
  47. Wee, 1981, Hum Immunol, 3, 45, 10.1016/0198-8859(81)90042-2 · doi:10.1016/0198-8859(81)90042-2
  48. Gong, 1994, Leukemia, 8, 652
  49. editor. TNM classification of tumors in domestic animals. 1st edition. Geneva: World Health Organization, 1980.
  50. Ogilvie, 1993, J Am Vet Med Assoc, 202, 304, 10.2460/javma.1993.202.02.304 · DOI
  51. Withrow, 1991, Clin Orthop, 270, 159, 10.1097/00003086-199109000-00023 · DOI · Paper page
  52. Brodey, 1977, J Am Vet Med Assoc, 168, 1032
  53. Spodnick, 1992, J Am Vet Med Assoc, 200, 995, 10.2460/javma.1992.200.07.995 · DOI · Paper page
  54. Powers, 1993, Cancer, 71, 2484, 10.1002/1097-0142(19930415)71:8<2484::AID-CNCR2820710810>3.0.CO;2-D · doi:10.1002/1097-0142(19930415)71:8<2484::aid-cncr2820710810>3.0.co;2-d
  55. Shapiro, 1988, J Am Vet Med Assoc, 192, 507
  56. MacEwen, 1989, J Natl Cancer Inst, 81, 935, 10.1093/jnci/81.12.935 · DOI · Paper page
  57. Kurzman, 1995, Clin Cancer Res, 1, 1595
  58. Foon, 1989, Cancer Res, 49, 1621
  59. Lorenz, 1996, Clin Cancer Res, 2, 1115
  60. Fabian, 1994, Leukemia, 8, 1379
  61. Milne, 1995, Int Arch Allergy Immunol, 108, 60, 10.1159/000237119 · doi:10.1159/000237119
  62. Rivoltini, 1993, Int J Cancer, 54, 8, 10.1002/ijc.2910540103 · DOI
  63. Ishimitsu, 1993, Surgery, 113, 192
  64. Sencer, 1991, Eur Cytokine Netw, 2, 311
  65. Kilbourn, 1994, J Appl Physiol, 76, 1130, 10.1152/jappl.1994.76.3.1130 · doi:10.1152/jappl.1994.76.3.1130
  66. Knapp, 1995, Gene, 159, 281, 10.1016/0378-1119(95)00078-K · DOI

Cited by

See all 561

Metadata

Authors
Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S.
Venue
Cancer
Publisher
Wiley
Published
1997-04-01
Volume
79
Issue
7
Pages
1409-1421
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
DOI
10.1002/(sici)1097-0142(19970401)79:7
OpenAlex
W2046796218
Cited by
561
References
22
FWCI
6.67
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6727 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. https://app.cochat.ai/papers/10.1002/(sici)1097-0142(19970401)79:7
The paper
Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S. (1997). Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer. https://doi.org/10.1002/(sici)1097-0142(19970401)79%3A7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.